Aura Preclinical Data Presented at ARVO 2021 »
Development of AU-011 for Choroidal Metastasis
Aura Preclinical Data Presented at ARVO 2021 »
Ocular Distribution and Exposure of AU-011 After Suprachoroidal or Intravitreal Administration in an Orthotopic Rabbit Model of Human Uveal Melanoma
Dr. Carol Shields Presents Overview of AU-011 at AAO 2020 »
AU-011, a Targeted Therapy for Primary Treatment of Choroidal Melanoma (CM) via Intravitreal (IVT) or Suprachoroidal (SC) Administration
Aura Preclinical Data Presented at ARVO 2020 »
Ocular Distribution and Efficacy After Suprachoroidal Injection of AU-011 for Treatment of Ocular Melanoma” – Presented at AVRO 2020
Aura Phase 1B/2 Results Presented at ARVO 2020 »
An Ongoing Phase 1B/2 Open-Label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma – Study Update” – Presented at ARVO 2020